NCT02332356View on ClinicalTrials.gov

Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Crohn Disease
Interventions
DRUG

azathioprine or adalimumab and infliximab

Trial Locations (1)

113-8519

Gastroenterology and Hepatology, Tokyo Medical and Dental UNIV, Tokyo

All Listed Sponsors
lead

Tokyo Medical and Dental University

OTHER